Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Experimental Hematology|May 15, 2026
From Gamma to X: Same destination but different journey ?Alexandre Fagnan
Hemasphere|April 26, 2021
Molecular Landscapes and Models of Acute ErythroleukemiaAlexandre Fagnan, Maria-Riera Piqué-Borràs, Samantha Tauchmann, et al.
Stem Cell Reports|June 11, 2026
Multiome-based identification of molecular markers for prospective identification of platelet-biased HSCsBowen Zhang, Yiran Meng, Esther Rodríguez Correa, et al.
Nature|March 12, 2026
A mechanism to initiate emergency type 2 myelopoiesisAlexandre Fagnan, Cristina Di Genua, Yiran Meng, et al.
Oncogene|January 26, 2018
PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcomaJason A Hanna, Matthew R Garcia, Alicia Lardennois, et al.
Blood|February 3, 2023
The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53Maria-Riera Piqué-Borràs, Zivojin Jevtic, Frederik Otzen Bagger, et al.
Hemasphere|June 21, 2024
The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness programAlexandre Fagnan, Zakia Aid, Marie Baille, et al.
Leukemia|December 30, 2022
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemiaZakia Aid, Elie Robert, Cécile K Lopez, et al.
Cancer Discovery|October 31, 2019
Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid LeukemiaCécile K Lopez, Esteve Noguera, Vaia Stavropoulou, et al.
Blood|May 1, 2020
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease driversAlexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, et al.
Pageof 1